Nutritional supplements and therapeutic compositions comprising (r)-3- hydroxybutyrate derivatives
US-2018195096-A1 · Jul 12, 2018 · US
US11814664B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11814664-B2 |
| Application number | US-201414893510-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 23, 2014 |
| Priority date | May 24, 2013 |
| Publication date | Nov 14, 2023 |
| Grant date | Nov 14, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are non-naturally occurring microbial organisms having a pathway for production of (3R)-hydroxybutyl (3R)-hydroxybutyrate, wherein the organism can further include a (R)-1,3-butanediol pathway, a (3R)-hydroxybutyrate pathway, a (3R)-hydroxybutyryl-CoA pathway, an acetoacetate pathway, an acetoacetyl-CoA pathway, a (3R)-hydroxybutyl-ACP pathway, or an acetoacetyl-ACP pathway. Additionally provided are methods and processes for producing and isolating (3R)-hydroxybutyl (3R)-hydroxybutyrate using the microbial organisms, and various compositions having the (3R)-hydroxybutyl (3R)-hydroxybutyrate. Still further provided are methods of treating or preventing a disease, disorder or condition using the (3R)-hydroxybutyl (3R)-hydroxybutyrate produced by the microbial organisms of the invention.
Opening claim text (preview).
What is claimed is: 1. A non-naturally occurring microbial organism, said microbial organism having a (3R)-hydroxybutyl (3R)-hydroxybutyrate pathway, wherein said (3R)-hydroxybutyl (3R)-hydroxybutyrate pathway comprises one or more (3R)-hydroxybutyl (3R)-hydroxybutyrate pathway enzymes selected from: (1) 1A; (2) 1B; (3) 1C and 1E; (4) 1D and 1E; (5) 1F; and (6) 1G and 1E, wherein 1A is a (3R)-hydroxybutyl (3R)-hydroxybutyrate ester forming enzyme, wherein 1B is a (3R)-hydroxybutyryl-CoA:(R)-1,3-butanediol alcohol transferase, wherein 1C is a (3R)-hydroxybutyl 3-oxobutyrate ester forming enzyme, wherein 1D is an acetoacetyl-CoA:(R)-1,3-butanediol alcohol transferase, wherein 1E is a (3R)-hydroxybutyl 3-oxobutyrate reductase, wherein 1F is a (3R)-hydroxybutyryl-ACP:(R)-1,3-butanediol ester synthase, wherein 1G is an acetoacetyl-ACP:(R)-1,3-butanediol ester synthase, wherein the (3R)-hydroxybutyl (3R)-hydroxybutyrate pathway enzyme is encoded by at least one exogenous nucleic acid and is expressed in a sufficient amount to produce (3R)-hydroxybutyl (3R)-hydroxybutyrate. 2. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises exogenous nucleic acids encoding each of the enzymes of at least one of the pathways selected from (1)-(6). 3. The non-naturally occurring microbial organism of claim 1 , wherein said at least one exogenous nucleic acid is a heterologous nucleic acid. 4. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism is a species of bacteria, yeast, or fungus. 5. A method for producing (3R)-hydroxybutyl (3R)-hydroxybutyrate, comprising culturing the non-naturally occurring microbial organism of claim 1 under conditions and for a sufficient period of time to produce (3R)-hydroxybutyl (3R)-hydroxybutyrate. 6. A non-naturally occurring microbial organism, said microbial organism having a (3R)-hydroxybutyl (3R)-hydroxybutyrate pathway, wherein said (3R)-hydroxybutyl (3R)-hydroxybutyrate pathway comprises one or more (3R)-hydroxybutyl (3R)-hydroxybutyrate pathway enzymes selected from: (1) 1A; (2) 1B; (3) 1C and 1E; (4) 1D and 1E; (5) 1F; and (6) 1G and 1E, wherein 1A is a (3R)-hydroxybutyl (3R)-hydroxybutyrate ester forming enzyme, wherein 1B is a (3R)-hydroxybutyryl-CoA:(R)-1,3-butanediol alcohol transferase, wherein 1C is a (3R)-hydroxybutyl 3-oxobutyrate ester forming enzyme, wherein 1D is an acetoacetyl-CoA:(R)-1,3-butanediol alcohol transferase, wherein 1E is a (3R)-hydroxybutyl 3-oxobutyrate reductase, wherein 1F is a (3R)-hydroxybutyryl-ACP:(R)-1,3-butanediol ester synthase, wherein 1G is an acetoacetyl-ACP:(R)-1,3-butanediol ester synthase, wherein the (3R)-hydroxybutyl (3R)-hydroxybutyrate pathway enzyme is encoded by at least one exogenous nucleic acid.
Carboxylic acid esters · CPC title
Bacteria or derivatives thereof, e.g. probiotics · CPC title
of acyclic acids, e.g. pravastatin · CPC title
Microorganisms or materials therefrom (fungi, yeasts or candida A61K36/06) · CPC title
Saccharomycetales, e.g. baker's yeast · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.